Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release

Journal of Neurochemistry

Volumn 93, Issue 5, 2005, Pages 1353-1360

  Grilli, Massimo ^a   Parodi, Monica ^a   Raiteri, Maurizio ^a   Marchi, Mario ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b Pharmacology and Toxicology Section ^*  (Italy)

Author keywords

Acetylcholine release; Chronic nicotine; Dopamine release; Glutamate release; Nicotinic receptor subtypes; Noradrenaline release

Indexed keywords

ASPARTIC ACID; AUTORECEPTOR; EPIBATIDINE; NICOTINE; NICOTINIC RECEPTOR; POTASSIUM; RECEPTOR SUBTYPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DOPAMINE RELEASE; EXOCYTOSIS; LONG TERM CARE; MALE; NERVE FIBER; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEUS ACCUMBENS; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; REGULATORY MECHANISM; SYNAPTOSOME;

ACETYLCHOLINE; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; D-ASPARTIC ACID; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HIPPOCAMPUS; MALE; NEUROTRANSMITTER AGENTS; NICOTINE; NICOTINIC AGONISTS; NOREPINEPHRINE; POTASSIUM; PROTEIN ISOFORMS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SYNAPTOSOMES;

ANIMALIA;

EID: 20144383118     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03126.x     Document Type: Article

References (49)

1. 3H]-NE from rat brain slices using a new 96-well format assay. Neuropharmacology 39, 2663-2672.
2. Aston-Jones G. (2002) Norepinephrine, in Neuropsychopharmacology: the Fifth Generation of Progress, American College of Neuropsychopharmacology (Davis K. L., Charney D., Coyle J. T., Nemeroff C., eds), pp. 47-58. Lippincott Williams & Wilkins, Philadelphia PA.
3. Bannermann D. M., Good M. A., Butcher S. P., Ramsay M. and Morris R. G. M. (1995) Distinct components of spatial learning revealed by prior training and NMDA receptor blockade. Nature 378, 182-186.
4. Benowitz N. L. (1990) Pharmacokinetic considerations in understanding nicotine dependence. Ciba Foundation Symp. 152, 186-200.
5. Berridge C. W. and Waterhouse B. D. (2003) The locus coeraleus- noradrenergic system: modulation of behavioral sate and state-dependent cognitive processes. Brain Res. Rev. 42, 33-84.
6. Bliss T. V. P. and Collingridge G. L. (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.
7. Buisson B. and Bertrand D. (2001) Chronic exposure to nicotine upregulates the human α4β2 nicotinic acetylcholine receptor function. J. Neurosci. 21, 1819-1829.
8. Buisson B. and Bertrand D. (2002) Nicotine addiction: the possible role of functional upregulation. Trends Pharmacol. Sci. 23, 130-136.
9. Cahill L., Prins B., Weber M. and McGaugh J. L. (1994) Beta-adrenergic activation and memory for emotional events. Nature 371, 702-704.
10. Champtiaux N., Gotti C., Cordero-Erausquin M. et al. (2003) Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J. Neurosci. 23, 7820-7829.
11. 3H]-dopamine release. Br. J. Pharmacol. 117, 595-606.
12. Dajas-Bailador F. and Wonnacott S. (2004) Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol. Sci. 25, 317-324.
13. Fedele E., Varnier G., Ansaldo M. A. and Raiteri M. (1998) Nicotine administration stimulates the in vivo N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release. Br. J. Pharmacol 125, 1042-1048.
14. Flores C. M., Davila-Garcia M. I., Ulrich Y. M. and Keller K. J. (1997) Differential regulation of neuronal nicotinic receptor binding sites following chronic (-)-nicotine administration. J. Neurochem. 69, 2216-2219.
15. Friedman J. I., Adler D. N. and Davis K. L. (1999) The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease. Biol Psychiatry 46, 1243-1252.
16. Gray R., Rajan A. S., Radcliffe K. A., Yakehiro M. and Dani J. A. (1996) Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383, 713-716.
17. Jacobs I., Anderson D. J., Surowy C. S. and Puttfarcken P. S. (2002) Differential regulation of nicotinic receptor-mediated neurotransmitter release following chronic (-)-nicotine administration. Neuropharmacology 43, 847-856.
18. Jia L., Flotildes K., Li M. and Cohen B. N. (2003) Nicotine trapping causes the persistent desensitization of α4β2 nicotinic receptors expressed in oocytes. J Neurochem. 84, 753-766.
19. Kulak J. M., McIntosh J. M., Yoshikami D. and Olivera B. M. (2001) Nicotine-evoked transmitter release from synaptosomes: functional association of specific presynaptic acetylcholine receptors and voltage-gated calcium channels. J Neurochem. 77, 1581-1589.
20. 3H]methylcarbamylcholine binding sites in rat brain. J. Neurochem. 52, 483-491.
21. Marchi M. and Raiteri M. (1996) Nicotinic autoreceptors mediating enhancement of acetylcholine release become operative in conditions of impaired presynaptic function. J. Neurochem. 67, 1974-1981.
22. Marchi M., Risso F., Viola C., Cavazzani P. and Raiteri M. (2002) Direct evidence that release-stimulating α7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals. J. Neurochem. 80, 1071-1078.
23. Marks M. J., Burch J. B. and Collins A. C. (1983) Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J. Pharmacol. Exp. Ther. 226, 817-825.
24. Marks M. J., Stitzel J. A. and Collins A. C. (1985) Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J. Pharmacol Exp. Ther. 235, 619-628.
25. Marks M. J., Grady S. R. and Collins A. C. (1993) Down regulation of nicotinic receptor function after chronic nicotine infusion. J. Pharmacol. Exp. Ther. 266, 1268-1276.
26. Marshall D. L., Redfern P. H. and Wonnacott S. (1997) Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats. J. Neurochem. 68, 1511-1519.
27. McGehee D. S., Heath M. J., S., Gelber S., Devay P. and Role L. W. (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269, 1692-1696.
28. Molinari E. J., Delbono O., Messi M. L., Renganathan M., Arneric S. P., Sullivan J. P. and Gopalakrishnan M. (1998) Up-regulation of human α7 nicotinic receptors by chronic treatment with activator and antagonist ligands. Eur. J. Pharmacol. 347, 131-139.
29. Murrin L. C., Ferrer J. R., Zeng W. Y. and Haley N. J. (1987) Nicotine administration to rats: methodological considerations. Life Sci. 40, 1699-1708.
30. Newhouse P. A., Potter A. and Singh A. (2004) Effects of nicotinic stimulation on cognitive performance. Curr. Opin. Pharmacol. 4, 436-446.
31. Nguyen H. N., Rasmussen B. A. and Perry D. C. (2004) Binding and functional activity of nicotinic cholinergic receptors in selected rat brain regions are increased following long-term but not short-term nicotine treatment. J Neurochem. 90, 40-49.
32. Olale F., Gerzanich V., Kuryatov A., Wang F. and Lindstrom J. (1997) Chronic nicotine exposure differentially affects the function of human α3, α4 and α7 neuronal nicotinic receptor subtypes. J. Pharmacol. Exp. Ther. 283, 675-683.
33. Peng X., Gerzanich V., Anand R., Whiting P. J. and Lindstrom J. (1994) (-)-Nicotine-induced increase in neuronal receptors results from a decrease in the rate of receptor turnover. Mol. Pharmacol. 46, 523-530.
34. Raiteri L. and Raiteri M. (2000) Synaptosomes still viable after 25 years of superfusion. Neurochem. Res. 25, 1265-1274.
35. Raiteri M., Angelini F. and Levi G. (1974) A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur. J. Pharmacol 25, 411-414.
36. Risso F., Grilli M., Parodi M., Bado M., Raiteri M. and Marchi M. (2004a) Nicotine exerts a permissive role on NMDA receptor function in hippocampal noradrenergic terminals. Neuropharmacology 47, 65-71.
37. Risso F., Parodi M., Grilli M., Molfino F., Raiteri M. and Marchi M. (2004b) Chronic nicotine causes functional upregulation of ionotropic glutamate receptors mediating hippocampal noradrenaline and striatal dopamine release. Neurochem. Int. 44, 293-301.
38. Salminen O., Murphy K. L., McIntosh J. M., Drago J., Marks M. J., Collins A. C. and Grady S. R. (2004) Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol. Pharmacol. 65, 1526-1535.
39. Sanderson E. M., Drasdo A. L., McCrea K. and Wonnacott S. (1993) Upregulation of nicotinic receptors following continuous infusion of (-)-nicotine is brain-region specific. Brain Res. 617, 349-352.
40. Schwartz R. D. and Kellar K. J. (1983) Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 220, 214-216.
41. Sershen H., Balla A., Lajtha A. and Vizi E. S. (1997) Characterization of nicotinic receptors involved in the release of noradrenaline from hippocampus. Neuroscience 77, 121-130.
42. Sharples C. G., Kaiser S., Soliakov L. et al. (2000) UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4-beta2 subtype in the modulation of dopamine release from rat striatal synaptosomes. J Neurosci. 20, 2783-2791.
43. Toth E., Vizi E. S. and Lajtha A. (1993) Effect of nicotine on levels of extracellular amino acids in regions of the rat brain in vivo. Neuropharmacology 32, 827-832.
44. 3H]-epibatidine binding sites. Neuropharmacology 36, 1119-1125.
45. Vizi E. S. and Lendvai B. (1999) Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system. Brain Res. Rev. 30, 219-235.
46. Wang L., Kittaka M., Sun N., Schreiber S. S. and Zlokovic B. V. (1997) Chronic nicotine treatment enhances focal ischemic brain injury and depletes free pool of brain microvascular tissue plasminogen activator in rats. J. Cereb. Blood Flow Metab. 17, 136-146.
47. Wilkie G. I., Hutson P., Sullivan J. P. and Wonnacott S. (1996) Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes. Neurochem. Res. 21, 1141-1148.
48. Wonnacott S. (1997) Presynaptic nicotinic ACh receptors. Trends Neurosci. 20, 92-98.
49. Zoli M., Moretti M., Zanardi A., McIntosh J. M., Clementi F. and Gotti C. (2002) Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J. Neurosci. 22, 8785-8789.